- Home
- WST vs ASX Comparison
WST vs ASX Comparison
Compare WST & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- ASX
- Stock Information
- Founded
- WST 1923
- ASX 1984
- Country
- WST United States
- ASX Taiwan
- Employees
- WST N/A
- ASX N/A
- Industry
- WST Medical/Dental Instruments
- ASX Semiconductors
- Sector
- WST Health Care
- ASX Technology
- Exchange
- WST Nasdaq
- ASX Nasdaq
- Market Cap
- WST 15.6B
- ASX 23.1B
- IPO Year
- WST N/A
- ASX 1995
- Fundamental
- Price
- WST $227.12
- ASX $10.44
- Analyst Decision
- WST Buy
- ASX Strong Buy
- Analyst Count
- WST 7
- ASX 1
- Target Price
- WST $331.67
- ASX N/A
- AVG Volume (30 Days)
- WST 627.1K
- ASX 12.1M
- Earning Date
- WST 07-24-2025
- ASX 07-24-2025
- Dividend Yield
- WST 0.37%
- ASX 2.53%
- EPS Growth
- WST N/A
- ASX 6.14
- EPS
- WST 6.37
- ASX 0.23
- Revenue
- WST $2,895,800,000.00
- ASX $18,355,472,366.00
- Revenue This Year
- WST $3.38
- ASX $12.29
- Revenue Next Year
- WST $5.85
- ASX $11.92
- P/E Ratio
- WST $35.64
- ASX $21.59
- Revenue Growth
- WST N/A
- ASX 4.61
- 52 Week Low
- WST $187.43
- ASX $6.94
- 52 Week High
- WST $352.33
- ASX $12.86
- Technical
- Relative Strength Index (RSI)
- WST 59.84
- ASX 57.95
- Support Level
- WST $219.60
- ASX $9.92
- Resistance Level
- WST $233.84
- ASX $10.43
- Average True Range (ATR)
- WST 5.29
- ASX 0.20
- MACD
- WST 0.60
- ASX -0.04
- Stochastic Oscillator
- WST 66.82
- ASX 63.75
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About ASX ASE Technology Holding Co. Ltd. (each representing Two)
ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Packaging segment contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.